INS and diabetes mellitus: By altering glucagon-like peptide-1 (GLP-1), bile acid pathways, and short-chain fatty acid (SCFA) pathways, FMT has been shown to increase insulin sensitivity and is an innovative approach for resolving diseases in the gut microbiota by targeting to change the gut diversity, particularly in diabetes [22].